Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A

NCT02938585 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A

Interventions

DRUG: turoctocog alfa
DRUG: turoctocog alfa

Sponsor

Novo Nordisk A/S